Ranking season is here. Are you ready for what’s driving results this cycle?

I’ve spent my career working on quality performance and methodology, and what I see most often isn’t a hospital failing to deliver good care — it’s a hospital that doesn’t have a clear picture of how it’s actually performing right now. The data that feeds public rankings is delayed by a year or more. The methodologies that determine how performance is measured are constantly shifting. And the foundational data elements that rankings are built from don’t always accurately reflect what’s happening at the bedside. Closing those three gaps — concurrent visibility into performance, alignment with how external measurement systems actually work, and data that accurately reflects the care being delivered — is where the real work happens.

What ranking season actually measures — and what it misses

Healthcare quality rankings are a public representation of hospital performance across a range of clinical, safety, and patient experience measures. CMS Star Ratings aggregate dozens of measures across mortality, safety, readmissions, patient experience, and process quality. Leapfrog grades evaluate patient safety practices and outcomes. National specialty rankings programs evaluate hospitals on risk-adjusted outcomes measures, including survival rates, discharge-to-home rates, and related clinical performance indicators.

Each of these programs is measuring something real and important. But by the time results are published, they reflect a window of performance that has already passed — often by a year or more. Without a concurrent view into what’s driving your measures today, rankings tell you where you’ve been, not where you’re headed.

Without concurrent visibility into performance — the ability to see how your measures are trending before results are published — teams are left interpreting a rearview mirror instead of navigating in real time. At the same time, ranking methodologies are constantly shifting, and keeping pace with what each program is measuring, how measures are weighted, and where your organization may be exposed requires ongoing attention that most quality teams don’t have bandwidth for. And when the foundational data elements that rankings are built from don’t accurately reflect what happened at the bedside, even strong clinical performance can appear worse than it is. Tendo Insights is built to help health systems address all three: continuous performance monitoring, methodology intelligence, and data accuracy.

What’s changing this year — and why it matters

Three major developments are shaping this ranking season.

CMS Star Ratings continue to evolve — introducing new measures, expanding patient populations, and updating methodologies in ways that can shift a hospital’s standing even when underlying performance hasn’t changed. That means a hospital’s results on any given measure don’t exist in isolation — they can shift because new measures have been introduced that were never previously evaluated, or because patient populations like Medicare Advantage have been included for the first time, changing the performance landscape even when underlying care hasn’t changed. Understanding where you stand within your peer group, and how methodological changes may affect that position, is increasingly important for anticipating what comes next.

Leapfrog Hospital Safety Grades are now published, and for many hospitals, the results raise questions: Why did our grade change? Which measures had the most impact? Where are the documentation and performance gaps that may be holding us back? The grade is public, but the underlying drivers often require deeper analysis to surface.

National specialty rankings programs are placing increased emphasis on risk-adjusted outcomes, including survival rates and discharge-to-home performance. Measures that previously carried less weight may now significantly influence where a hospital stands.

Taken together, these changes mean that waiting for next year’s results is not a strategy. The teams that perform best in future cycles are already working to understand where they stand today.

Why quality strategy starts before the rankings are published

The conversation I find myself having most often with quality and CDI leaders starts in the same place: rankings are out, results are unexpected, and the team is working backward trying to understand what happened. That reactive cycle is hard to break — but it’s also unnecessary.

The first step is understanding how methodology changes affect your specific position. New measures, updated weightings, and expanded patient populations don’t affect all hospitals equally. A change that has minimal impact on one organization can meaningfully shift another’s peer group standing or specialty-level ranking. Knowing which methodological changes create exposure for your organization — before results are published — is what separates teams that are prepared from teams that are surprised.

The second is having concurrent visibility into how your measures are actually trending. Most quality teams are working from data that is years old by the time it reaches them. A continuous view of performance — across measures, service lines, and facilities — gives leaders the ability to identify where gaps are opening and course-correct in real time, rather than after the fact.

Data accuracy is the third lever, and it’s one of the most underestimated. Rankings are only as reliable as the data they’re built from — and when that data doesn’t fully reflect what happened clinically, performance suffers on paper regardless of what happened at the bedside. Documentation and coding accuracy are two of the most direct places where this gap opens. The specificity that matters for quality rankings is different from what drives reimbursement: comorbidities that affect mortality risk adjustment, conditions that influence measure exclusions, and the clinical detail that determines whether a complication was present before admission or acquired during a hospital stay. These distinctions have direct effects on how a hospital performs in CMS Stars, Leapfrog, and national specialty ranking programs — and they’re often invisible to teams that aren’t specifically looking for them. Getting the data right isn’t about compliance or revenue — it’s about making sure the care your teams deliver is fully and accurately reflected in the measures that rankings are built from.

What health systems should be doing right now

Ranking season is a good time to do three things.

1. Understand what actually drove this year’s results. Not just the score, but the measure-level performance, the peer group position, and the new methodology that may have influenced performance. This is the diagnostic step that most teams skip — they see the result, have a board conversation, and move on. The teams that improve are the ones that take time to understand the mechanism and align with current ongoing performance.
2. Assess your exposure to new methodology changes. If your hospital has performance tied to measures that were retired or re-engineered, now is the time to understand where your risk-adjusted performance may be vulnerable. Waiting for the new rankings to be published is waiting too long.
3. Connect your documentation improvement strategy to your quality ranking goals — explicitly. CDI and quality improvement often operate as separate workstreams, but the most effective organizations have aligned them around shared performance targets. What comorbidities, if captured more consistently, would improve your CMS Stars risk adjustment? What specificity improvements would reduce apparent complication rates in your specialty ranking program outcomes data?

Understanding your performance now so you can prepare for what’s next

When rankings shift — in either direction — the most important question isn’t “what’s our score?” It’s “why did it change?” And that answer is rarely simple. A change in performance can be clinical, driven by genuine shifts in outcomes or patient safety. It can be methodological, driven by how a program has changed what it measures or how it weights results. Or it can be a data accuracy issue, where the care being delivered isn’t fully reflected in the measures. Most of the time, it’s some combination of all three.

That distinction matters because the response is different in each case. A clinical performance gap requires operational intervention. A methodology shift requires modeling and anticipation. A data accuracy gap requires targeted improvement in how care is captured and coded. Getting to the right answer — and the right action — starts with understanding which of those forces is actually at work for your organization, right now, not after the next cycle publishes.

That’s the conversation I most want to be having with quality and CDI leaders this season. If you’re looking at your rankings and trying to separate signal from noise — to understand whether what changed is clinical, methodological, or data-driven — I’d welcome 30 minutes together. No pitch, just a substantive conversation about what’s actually on your desk.